https://doi.org/10.4081/reumatismo.2017.968

Jaccoud’s arthropathy, an unusual manifestation of idiopathic retroperitoneal fibrosis: rapid improvement of symptoms after tocilizumab treatment

Vol. 69 No. 2 (2017)
Submitted: 22 January 2017
Accepted: 10 May 2017
Published: 3 August 2017
Jaccoud’s arthropathy, Idiopathic Retroperitoneal fibrosis, Tocilizumab.
Abstract Views: 1845
PDF: 915
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

M. Benucci
maurizio.benucci@uslcentro.toscana.it
Rheumatology Unit, San Giovanni di Dio Hospital, Florence, Italy.
A. Damiani
Rheumatology Unit, San Giovanni di Dio Hospital, Florence, Italy.
F. Li Gobbi
Rheumatology Unit, San Giovanni di Dio Hospital, Florence, Italy.
V. Grossi
Immunology and Allergology Laboratory, San Giovanni di Dio Hospital, Florence, Italy.
M. Infantino
Immunology and Allergology Laboratory, San Giovanni di Dio Hospital, Florence, Italy.
A. Arena
Nuclear Medicine, New Hospital, Prato, Italy.
M. Manfredi
Immunology and Allergology Laboratory, San Giovanni di Dio Hospital, Florence, Italy.
Jaccoud’s arthropathy (JA) is a chronic, non erosive, rheumatoid-like deformity associated with rheumatic fever (RF) and systemic lupus erythematosus and with other diseases such as psoriatic arthritis, connective tissue diseases, hypocomplementemic urticarial vasculitis, infections, sarcoidosis and neoplasia. We described a case of JA in a patient with cutaneous psoriasis but with a particular disease evolution associated with idiopathic retropritoneal fibrosis (IRF), evaluated with computed tomography, magnetic resonance and 18F-FDG PET/ CT. The patient, following failure with steroids, methotrexate and etanercept, was treated with tocilizumab (8 mg/kg) once every 4 weeks for 6 months. A rapid improvement of symptoms and disappearance of 18F-FDG uptake was shown. We describe a review of literature of rheumatic manifestations of IRF and the possible role of interleukin-6 in the pathway of JA and IRF.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

How to Cite

Benucci, M., Damiani, A., Li Gobbi, F., Grossi, V., Infantino, M., Arena, A., & Manfredi, M. (2017). Jaccoud’s arthropathy, an unusual manifestation of idiopathic retroperitoneal fibrosis: rapid improvement of symptoms after tocilizumab treatment. Reumatismo, 69(2), 88–91. https://doi.org/10.4081/reumatismo.2017.968

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.

Similar Articles

<< < 1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.